CCL18 and systemic sclerosis: Circulating monocytes of SSc-ILD patients show a prevalent M2 phenotype, expressing CD163, CD204 (macrophage scavenger receptors and M2 markers) and CD206 (mannose receptor-1) as M2 cell membrane markers, and producing IL-10 and CCL-18 (14–17).